Literature DB >> 12832686

Lung cancer. 6: The case for limited surgical resection in non-small cell lung cancer.

D J Sugarbaker1.   

Abstract

The choice between conservative resection or standard anatomical resection for stage I NSCLC depends on the size and biology of the tumour and the age and state of health of the patient.

Entities:  

Mesh：

Year:  2003        PMID： 12832686      PMCID： PMC1746726          DOI： 10.1136/thorax.58.7.639

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  7 in total

1.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

2.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

3.  Clinical analysis of small-sized peripheral lung cancer.

Authors:  T Koike; M Terashima; T Takizawa; T Watanabe; Y Kurita; A Yokoyama
Journal:  J Thorac Cardiovasc Surg       Date:  1998-05       Impact factor: 5.209

4.  Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.

Authors:  R J Landreneau; D J Sugarbaker; M J Mack; S R Hazelrigg; J D Luketich; L Fetterman; M J Liptay; S Bartley; T M Boley; R J Keenan; P F Ferson; R J Weyant; K S Naunheim
Journal:  J Thorac Cardiovasc Surg       Date:  1997-04       Impact factor: 5.209

5.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

6.  Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence.

Authors:  W H Warren; L P Faber
Journal:  J Thorac Cardiovasc Surg       Date:  1994-04       Impact factor: 5.209

7.  Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

Authors:  D J Kwiatkowski; D H Harpole; J Godleski; J E Herndon; D B Shieh; W Richards; R Blanco; H J Xu; G M Strauss; D J Sugarbaker
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544
  7 in total
  5 in total

1.  Differential expression of VASP in normal lung tissue and lung adenocarcinomas.

Authors:  L Dertsiz; G Ozbilim; Y Kayisli; G A Gokhan; A Demircan; U A Kayisli
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

2.  Predictors and outcomes of limited resection for early-stage non-small cell lung cancer.

Authors:  Sarah E Billmeier; John Z Ayanian; Alan M Zaslavsky; David R Nerenz; Michael T Jaklitsch; Selwyn O Rogers
Journal:  J Natl Cancer Inst       Date:  2011-09-29       Impact factor: 13.506

3.  Thermal Ablation Versus Wedge Resection for Stage I Non-small Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database.

Authors:  Chenxi Zeng; Jiawei Lu; Yitao Tian; Xiangning Fu
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244

4.  Ten-year follow-up of a province-wide cohort of surgical lung cancer patients in Nova Scotia.

Authors:  Daniel R Wong; Harry J Henteleff
Journal:  Can J Surg       Date:  2008-08       Impact factor: 2.089

5.  Is the initial feasibility of lobectomy for stage I non-small cell lung cancer in severe heterogeneous emphysema justified by long-term survival?

Authors:  Antonio E Martin-Ucar; Khaleel R Fareed; Apostolos Nakas; Paul Vaughan; John G Edwards; David A Waller
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.